Google's revenue growth was impacted by currency fluctuations in Q1, but improved profitability, regained search share in the US and focus on app distribution could drive growth in the coming quarters.
Facebook missed revenue estimates, dragged by currency fluctuations, while profitability declined, in line with expectations. Strong user growth across devices and growth in revenue per user augur well for revenue growth in the coming quarters.
Yahoo re-iterated its Q4 target for the Alibaba spin-off and is now mulling options to "handle" its stake in Yahoo Japan. As for Q1 financials, Yahoo reported a year on year growth in revenue, with sustained progress on mobile devices. Traffic acquisition costs spiked partly due to one time costs. Yahoo's projection of revenue growth and reduced TAC in Q2 2015 indicate a potentially stronger quarter ahead.
Qihoo has doubled its revenue every year, while managing to show significant improvements in its operating and net profit margins over a 3 year period. With its robust financials, and attractive valuations Qihoo is a good investment option for long term investors.
Twitter valuations are expensive going into Q1 earnings. Expect strong growth to continue in Q1. User growth, engagement levels and profitability hold the key in this Twitter earnings release.
Outbrain, the leader of the content recommendation market with a 25% share generated revenue of $260M in 2014, and a three year CAGR of 80%. Outbrain IPO could be valued at a very appealing PS multiple that will attract a high demand for the IPO. Within a reasonable price range, Outbrain IPO is an attractive IPO to participate in.
Top gaining stocks from internet industry
tech stocks news
Ubiquiti Networks to Report Third Quarter Fiscal 2015 Earnings Results on May 7, 2015 : Ubiquiti Networks (UBNT)
Blackbaud, Inc. Announces Company Presentation at the Jefferies Technology, Media & Telecom Investor Conference : Blackbaud (BLKB)
Charter to Hold Conference Call to Discuss First Quarter 2015 Financial and Operating Results : Charter Communications (CHTR)
YOUKU SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Youku Tudou, Inc. -- YOKU : Youku Tudou (YOKU)
Cray to Announce First Quarter 2015 Financial Results on Tuesday, May 5 at 4:30 P.M. ET : Cray (CRAY)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Youku Tudou, Inc. of Class Action Lawsuit and Upcoming Deadline - YOKU : Youku Tudou (YOKU)
MBC Deploys Infinera for Terabit Network Upgrade for Education, Research & Development and Big Data Projects : Infinera (INFN)
The information provided by newsletter are very compelling and it has assisted me in the decision making process and it has also created a better base for me to understand KOPN Stock, here are links of a few good newsletters, perfectpennystocks.com/signup and vippennystocksite.com
The information provided by newsletter are very compelling and it has assisted me in the decision making process and it has also created a better base for me to understand DCNPF Stock, here are links of a few good newsletters, perfectpennystocks.com/signup and vippennystocksite.com
Keep a close eye on eHealth, Inc. (EHTH). The company delivered its quarterly financial results with profit and revenue numbers that exceeded analysts' expectations Read more at Mike Zaman website http://mikezaman.com/33823/stocks/ehealth-ehth-surprise-quarterly-numbers-aarons-aan-solid-profitability/
Cari Genteng yang kuat&kokoh? Kami punya solusinya. PT Pelita Mas menyediakan jenis genteng beton yang kuat dengan bahan yang kualitas. Basecamp: Jl Raya Kedawung No. 99, Karangploso, Ngijo, Malang More info? Hubungi Lia 085695495866(Indosat) dan Ibu Nadiyah 082186148884 (SIMPATI) Kunjungi juga website kami: http://jualgentengbeton.com/
Watch GW Pharmaceuticals(GWPH) stock, which reached all-time high levels during Friday's trading session as the company said that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Cannabidiol for the treatment of newborn children with neonatal hypoxic-ischemic encephalopathy Read more at Mike Zaman website http://mikezaman.com/33807/stocks/gw-pharmaceuticals-gwph-at-all-time-high-levels-on-cannabidiol-fda-status-amazon-amzn-soars-on-sales-growth/
trending articles & stock analysis